Search results
This High-Yield Dividend Stock Is a Proven Wealth Creator
Motley Fool· 7 months agoFound in 1849, Pfizer (NYSE: PFE) has transformed the lives of patients and shareholders alike. In...
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
Reuters via Yahoo Finance· 1 month agoDrugmaker Viatris narrowly missed first-quarter revenue estimates on Thursday, hurt by weak sales for its older drugs such as cholesterol medication Lipitor and Norvasc for high blood pressure ...
Want to Collect $1,100 in Dividends? Invest $20,000 in These 2 Stocks
Motley Fool· 1 year agoIf you have $20,000 or more in savings that you can afford to invest in stocks, you may want to...
2 Dirt Cheap Dividend Stocks to Buy and Hold
Motley Fool via Yahoo Finance· 3 months agoDividend stocks are great for several reasons. Some use the regular payouts they offer to complement their income, whether in retirement or otherwise,...
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
Motley Fool· 2 years agoHere's why they chose Bristol Myers Squibb (NYSE: BMY), Viatris (NASDAQ: VTRS), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (Bristol...
Viatris reaffirms 2023 sales forecast on strong demand for newer drugs
Reuters via Yahoo Finance· 1 year ago(Reuters) - Viatris Inc reaffirmed its full-year revenue forecast on Monday and said it was on track to achieve about $500 million in annual sales from its newly launched products, sending its ...
If You'd Invested $25,000 in Viatris in 2020, This Is How Much You Would Have Today
Motley Fool· 10 months agoViatris (NASDAQ: VTRS) spun off from Pfizer and merged with Mylan back in 2020. It's a generic...
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
Motley Fool· 9 months agoIf you're looking for a high-yield dividend stock in the healthcare sector, you might be interested...
1 Magnificent S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
Motley Fool via Yahoo Finance· 3 months agoGiven its key role in the fight against COVID-19, the fact that Pfizer (NYSE: PFE) shares are down...
2 Undervalued Growth Stocks With Long-Term Prospects That Are Ready to Rise
Motley Fool· 1 year agoThe long-term thesis for Viatris (NASDAQ: VTRS) rests on its drug pipeline, researching and...